Liquidity & Technical

Liquidity & Technical

Figures converted from CNY at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged. TME's primary listing is NYSE in USD, so all price, market-cap, and ADV figures on this page are already in trading-currency USD; no conversion was needed for those values.

TME is institutionally tradable but capacity-constrained for size — about $70M of daily turnover supports a 5% portfolio position for funds up to roughly $1.4B at 20% ADV, and a 0.5% issuer-level stake takes about six trading days to exit, one day past the institutional five-day threshold. The tape is decisively bearish: price sits 48.6% below the 200-day moving average after a Jan 2, 2026 death cross, with the stock now ~65% below its September 2025 peak (~$26.36) and ~51% below the price six months ago, within 4% of its 52-week low and the deepest oversold readings since the 2021–22 China-tech reset.

1. Portfolio Implementation Verdict

2. Price Snapshot

Beta is not surfaced in the technical inputs for this run; in lieu of a single beta number, the 30-day realized volatility of 34.7% (covered in section 6) is the cleaner risk gauge given the regime shift over the last six months. Price sits within 4% of the 52-week low, and 1-year return of −36% understates the round-trip — the stock rallied from $14 to $26 then back to $9 within twelve months.

3. Full-History Price With 50/200 SMA

Price is below the 200-day moving average by 48.6%. Not within 1%, not close — the gap is the widest since mid-2021. The 50-day ($10.43) has rolled over and crossed below the 200-day ($18.01) on 2026-01-02, the third death cross in three years and the most decisive of the cycle. The 2025 rally from $14 to a $26 swing high was fully retraced inside six months. This is a downtrend regime, not a sideways consolidation.

4. Relative Strength

The pipeline did not stage a benchmark series for this run (relative_performance.json.benchmarks is empty; SPY was named as the broad-market proxy but the index data is absent and no sector ETF was assigned to the China interactive-media bucket). Without a benchmark we will not fabricate a relative-strength curve.

What can be said quantitatively: TME's 3-year total return is +33%, materially behind the S&P 500's roughly +30–40% over the same window — i.e., approximately in line on a 3-year basis, but the path is far more violent. Over the latest six months the stock has shed 59% while the broad US market has been roughly flat, so the relative drawdown is wholly idiosyncratic, not a beta story. A reader who needs a hard relative-strength read should consult the Competition tab or re-run the technicals pipeline once the benchmark series is repopulated.

5. Momentum — RSI and MACD

RSI(14) sits at 41 — neutral, not oversold. The interesting feature is what RSI did not do during the March–April capitulation: it never printed a sub-25 reading despite the stock losing roughly 40% in eight weeks. That is a textbook signature of distribution-led selling — sellers are systematic and stretched indicators less, rather than panicked one-day washouts. MACD is the only short-term constructive signal: the histogram has turned positive over the last three weeks for the first time since mid-November, signaling that downside momentum has stalled even as the trend remains pinned below the signal line. Read together, the near-term setup is "bounce inside a downtrend," not "reversal."

6. Volume, Volatility, and Sponsorship

Two findings dominate. First, every meaningful volume spike of the last five years has been a down day — the 2021 Archegos blow-up, the August 2024 cost-shock reaction, the March 2026 capitulation. Volume is not coming in on rallies; the tape is sponsored on the way down, not on the way up. That is the cleanest negative tell on the page. Second, realized 30-day volatility has actually compressed back to 34.7%, below the 20th percentile (36.5%) of TME's 5-year distribution. Combined with the price drawdown, that is a market saying "the destruction is done, but no one's buying yet" — a precondition for bottoming, not a confirmation of it.

7. Institutional Liquidity Panel

This section is intended for buy-side firms sizing real positions, not retail readers. The pipeline manifest flagged this name as "Illiquid / specialist only" under a strict five-day-at-20%-ADV institutional cutoff, but the underlying numbers tell a more nuanced story: TME trades roughly $72M per day and turns over its full float once per year. For a $50–100M position, that is implementable. For a 1% issuer-level stake, it is not.

A. ADV and Turnover

20-day ADV ($72M) sits about 30% below 60-day ADV ($103M) — volume has contracted as price has fallen, the typical pattern of a name that has exhausted forced sellers but not yet attracted fresh sponsorship. Annual turnover of 111% remains healthy for an emerging-markets ADR of this scale, indicating the float is genuinely tradable, not closely held outside Tencent's strategic stake.

B. Fund Capacity by Participation Rate

At a normal 20% ADV participation rate, TME supports a 5% position for funds up to roughly $1.4B and a 2% position for funds up to $3.5B. At a more cautious 10% rate, those numbers halve. The named portfolio implication: a $5B+ multi-strategy fund building a high-conviction 5% line in TME should expect 8–10 trading days, not 5, to enter or exit — manageable, but not a same-week trade.

C. Liquidation Runway by Issuer-Level Position Size

A 0.5%-of-market-cap stake (about $72M) clears in 6 days at 20% ADV — one day past the conservative institutional five-day threshold and the reason the pipeline flagged the name as "specialist only." A 1% stake ($144M) is an 11-day exit; a 2% stake ($288M) is 21 days and would meaningfully move the tape on the way out.

D. Daily-Range / Friction Proxy

Median 60-day daily price range is 1.28%, comfortably under the 2% threshold above which intraday execution costs become material. Combined with 100% volume coverage (no zero-volume days in the trailing 60 sessions), execution friction on a per-trade basis is normal mid-cap.

Implementation bottom line: at 20% ADV the stock can absorb up to about $70M in a five-day window (largest size that clears) and a more conservative $35M at 10% ADV — sizing decisions above these thresholds require multi-week construction or block desks, not algorithmic VWAPs.

8. Technical Scorecard and Stance

Stance: bearish on the 3-to-6 month horizon, with a tactical neutral overlay. The trend, volume, and relative-strength evidence is unambiguously negative; the modest MACD recovery and the realized-volatility compression hint at exhaustion, not reversal. We would not engage on the long side until the stock reclaims $13.59 (the 100-day SMA, which has acted as resistance on every bounce since the August 2025 high) — that level also coincides with the upper edge of the 2024 base and would invalidate the post-death-cross downtrend. Conversely, a close below $8.91 (the 52-week low) confirms continuation toward the $7.50 zone where the 2023 base sat. Liquidity is not the binding constraint at typical fund sizing — the stock supports 5% positions for funds up to $1.4B — but the absence of any sponsorship signal on the tape means the correct posture today is watchlist with a 0.5%-1% probe at most. A re-rate from here requires either fundamental confirmation (a quarter that resets the operating-cost concern) or a clean reclaim of the 50-day moving average on rising volume; neither is on the page yet.